Look for:

Our offer for

CENTOGENE NV COM EUR0.12


ISIN:
NL0014040206
WKN:
N1976T109

2024/06/26 08:10:47
Price
0.38 EUR
Difference 5.12% (0.02)

General attributes

ISINNL0014040206
SymbolCNTG
ExchangeDuesseldorf
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)11 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)0.38 EUR (2,700)
Ask (Ask size)0.3875 EUR (2,700)
Open0.38 EUR
High0.38 EUR
Low0.38 EUR
Close (prev. day)0.3615 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: CENTOGENE NV COM EUR0.12PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/06/26 08:10:47
Price
0.38 EUR
Difference 5.12% (0.02)

General attributes

ISINNL0014040206
SymbolCNTG
ExchangeDuesseldorf
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)11 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)0.38 EUR (2,700)
Ask (Ask size)0.3875 EUR (2,700)
Open0.38 EUR
High0.38 EUR
Low0.38 EUR
Close (prev. day)0.3615 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Performance and Risk

6m1Y3Y
Perf (%)-65.90%-51.54%-95.77%
Perf (abs.)-0.70-0.38-8.19
Beta0.511.090.70
Volatility72.9497.57103.05
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.36 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)0.34 EUR (7)
Ø price 100 days | Ø volume 100 days (pcs.)0.53 EUR (15)
Ø price 250 days | Ø volume 250 days (pcs.)0.83 EUR (8)
YTD High | date1.13 EUR (2024/01/18)
YTD Low | date0.31 EUR (2024/05/17)
52 Weeks High | date1.55 EUR (2023/06/28)
52 Weeks Low | date0.31 EUR (2024/05/17)

All listings for CENTOGENE NV COM EUR0.12

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2024/06/2609:150.3835 EUR0.002
Duesseldorf2024/06/2608:100.38 EUR0.001
Frankfurt2024/06/2608:050.37 EUR0.001
Hamburg2024/06/2608:160.37 EUR0.001
Munich2024/06/2608:030.3805 EUR0.001
Nasdaq2024/06/2522:300.399 USD0.0035
Stuttgart2024/06/2608:020.339 EUR0.001
Tradegate2024/06/2522:260.379 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=142389&ID_TYPE_IMAGE_LOGO=2

Contact Details

CENTOGENE NV
- -
Am Strande 7 - 18055 Rostock
Telefon: +49-381-80113400
Fax: +381-80113401
E-mail: -

PDF Downloads

Company report: CENTOGENE NV COM EUR0.12PDF Download

Company Profile

Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.

Members of Management Board

Kim StrattonChairman of Managing Board
Ian RentschMember of Executive Committee
Miguel Coego RiosMember of Executive Committee
Peter BauerMember of Executive Committee

Board of directors

Peer SchatzChairman of Supervisory Board
Eric SouêtreMember of Supervisory Board
Hubert BirnerMember of Supervisory Board
Jonathan SheldonMember of Supervisory Board
Guido PrehnMember of Supervisory Board
Mary SheahanMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer